Globus Medical, Inc.GMEDNYSE
Loading
GMED Revenue Growth (YoY Quarterly)•+25.73%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
+25.73%
+2.8pp
+51.10%
+14.1pp
+68.22%
-17.3pp
+184.83%
+4.1pp
+430.56%
+301.1pp
+452.63%
+321.1pp
+431.58%
+300.0pp
-1.15%
-0.3pp
-1.78%
+0.1pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +6.61% | -1.41% | +18.37% | +22.91% | +25.73% |
| Gross Profit Growth | +12.19% | +10.28% | +34.34% | +37.02% | +51.10% |
| EBITDA Growth | +49.60% | +93.52% | +53.07% | +85.54% | +68.22% |
| Operating Income Growth | +495.42% | +1113.00% | +53.38% | +180.69% | +184.83% |
| Net Income Growth | +76.30% | +0.00% | +538.68% | +129.50% | +430.56% |
| EPS Growth | +72.73% | +0.00% | +552.17% | +131.58% | +452.63% |
| EPS Diluted Growth | +72.73% | +0.00% | +547.83% | +131.58% | +431.58% |
| Weighted Average Shares Growth | -0.84% | +1.03% | +0.01% | -0.82% | -1.15% |
| Weighted Average Shares Diluted Growth | +0.50% | +3.26% | -0.35% | -1.93% | -1.78% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +100.95% | +238.44% | +43.51% | +22.61% | +18.18% |
| Free Cash Flow Growth | +136.24% | +471.80% | +18.30% | +35.36% | -0.43% |
| Receivables Growth | +14.55% | +0.64% | +7.46% | +16.00% | +17.40% |
| Inventory Growth | -22.27% | -18.70% | +0.22% | +7.50% | +15.18% |
| Asset Growth | +3.26% | -4.70% | -0.65% | +0.19% | +0.97% |
| Book Value per Share Growth | +5.37% | +3.16% | +8.02% | +8.99% | +10.76% |
| Debt Growth | +3.23% | -82.44% | -77.12% | -77.67% | -77.91% |
| R&D Expense Growth | -36.06% | -42.27% | +5.98% | +7.59% | +121.26% |
| SG&A Expenses Growth | +3.58% | -2.36% | +26.80% | +30.26% | +80.01% |
1 / 4